BioSpace News Archive

The company said it would halt activities and focus its resources and time on liver and obesity research following “disappointing” results of its intranasal COVID-19 vaccine.

Innate Pharma has an alternative to T cell-based immunotherapy that has the potential to quickly and safely eradicate solid and metastatic tumors in the body.

Life sciences news sometimes flies under the radar. So here’s a look at a few stories you may have missed.

The new funding will be used to advance the company’s potential best-in-class epidermal growth factor receptor tyrosine kinase inhibitor furmonertinib, a lung cancer treatment that has been licensed from Allist Pharmaceuticals.

Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, announced that data on its lead compound, devimistat, has been selected for an oral presentation at the 2021 European Society of Medical Oncology World Gastrointestinal Congress, taking place June 30 through July 3, 2021.

Nemaura Medical Inc. provided a business update and released financial results for the fiscal year ended March 31, 2021.

I-Mab today announced that it was ranked among the top companies by leading global financial publication Institutional Investor in both the “Honored Companies” and “Best CFO” categories, according to its 2021 All-Asia Executive Team survey.

Ambrx today announced the appointment of Sonja Nelson to Chief Financial Officer.

Check-Cap Ltd. announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale of 25,925,926 of the Company’s ordinary shares and accompanying short-term warrants to purchase up to an aggregate of 25,925,926 of the Company’s ordinary shares in a registered direct offering.

CytRx Corporation recently announced 24-month interim results of an open-label extension (OLE) trial of arimoclomol for the treatment of Niemann-Pick disease type C (NPC).